| 标题 |
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Nature Communications 作者:Angela Damato; Riziero Esposito Abate; Simona Tessitore; Daniela Frezzetti; Monica Rosaria Maiello; et al 出版日期:2026-03-25 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)